- Home
- ROIV vs AYI Comparison
ROIV vs AYI Comparison
Compare ROIV & AYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- AYI
- Stock Information
- Founded
- ROIV 2014
- AYI 2001
- Country
- ROIV United Kingdom
- AYI United States
- Employees
- ROIV N/A
- AYI N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- AYI Building Products
- Sector
- ROIV Health Care
- AYI Consumer Discretionary
- Exchange
- ROIV Nasdaq
- AYI Nasdaq
- Market Cap
- ROIV 7.8B
- AYI 8.5B
- IPO Year
- ROIV N/A
- AYI N/A
- Fundamental
- Price
- ROIV $11.45
- AYI $273.03
- Analyst Decision
- ROIV Buy
- AYI Hold
- Analyst Count
- ROIV 4
- AYI 4
- Target Price
- ROIV $17.50
- AYI $320.75
- AVG Volume (30 Days)
- ROIV 5.4M
- AYI 262.1K
- Earning Date
- ROIV 08-07-2025
- AYI 06-26-2025
- Dividend Yield
- ROIV N/A
- AYI 0.25%
- EPS Growth
- ROIV N/A
- AYI 10.20
- EPS
- ROIV N/A
- AYI 13.18
- Revenue
- ROIV $29,053,000.00
- AYI $3,958,300,000.00
- Revenue This Year
- ROIV $2.64
- AYI $14.03
- Revenue Next Year
- ROIV $378.09
- AYI $10.21
- P/E Ratio
- ROIV N/A
- AYI $20.72
- Revenue Growth
- ROIV N/A
- AYI 2.78
- 52 Week Low
- ROIV $8.73
- AYI $216.81
- 52 Week High
- ROIV $13.06
- AYI $345.30
- Technical
- Relative Strength Index (RSI)
- ROIV 57.83
- AYI 57.22
- Support Level
- ROIV $10.89
- AYI $266.24
- Resistance Level
- ROIV $11.79
- AYI $282.92
- Average True Range (ATR)
- ROIV 0.35
- AYI 6.03
- MACD
- ROIV 0.01
- AYI 0.29
- Stochastic Oscillator
- ROIV 62.57
- AYI 66.92
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About AYI Acuity Brands Inc.
Acuity is a leading industrial technology company that offers lighting, lighting controls, and intelligent building solutions. Acuity, Inc. designs, manufactures, and brings to market products and services relating to these and other offerings. Acuity, Inc. has two reportable segments: Acuity Brands Lighting and Acuity Intelligent Spaces. ABL sells commercial, architectural, and specialty lighting, including components and control systems. AIS offers building management and audio/visual solutions to help make buildings intelligent.